Narayanan M P, Kumar Ankur, Kumar Verma Ganesh, Bairwa Avinash, Mirza Anissa A, Goyal Bela
Biochemistry, All India Institute of Medical Sciences, Rishikesh, Rishikesh, IND.
Microbiology, All India Institute of Medical Sciences, Rishikesh, Rishikesh, IND.
Cureus. 2024 Oct 15;16(10):e71542. doi: 10.7759/cureus.71542. eCollection 2024 Oct.
We have attempted to summarize the efficacy of bacteriophage therapy, highlighting the recent advances and phage delivery methods in different clinical trials and animal studies for wound-associated infections. Bacteriophage therapy is the lyse of bacteria by bacteriophages at the site of invasion. As bacteria become more resistant to antibiotics, discovering an alternative is more important than ever, and bacteriophage therapy has yielded promising outcomes. A clear knowledge of the bacteriophage, microbiota, and human host and their interaction is necessary to implement bacteriophage treatment on a large scale. Much technological advancement and regulatory guidelines increased the credibility of phage therapy (PT). Still, the challenges include the development of efficient bacteriophage screening methods, phage therapy strategies for biofilms, and the quality and safety of phage preparations. However, much consideration is to be taken in designing a novel therapeutic approach for antibiotic-resistant infections by using phages, phage lytic proteins, bioengineered phages, or antibiotics in combination.
我们试图总结噬菌体疗法的疗效,重点介绍不同临床试验和动物研究中针对伤口相关感染的最新进展和噬菌体递送方法。噬菌体疗法是指噬菌体在入侵部位裂解细菌。随着细菌对抗生素的耐药性增强,寻找替代方法比以往任何时候都更加重要,而噬菌体疗法已取得了令人鼓舞的成果。要大规模实施噬菌体治疗,必须清楚了解噬菌体、微生物群和人类宿主及其相互作用。大量的技术进步和监管指南提高了噬菌体疗法(PT)的可信度。然而,挑战包括开发高效的噬菌体筛选方法、针对生物膜的噬菌体治疗策略以及噬菌体制剂的质量和安全性。不过,在设计一种使用噬菌体、噬菌体裂解蛋白、生物工程噬菌体或抗生素联合治疗耐抗生素感染的新方法时,需要考虑很多因素。